Home / Cancer and immune system / Infliximab
ATC L04AB02 · Immunosuppressants
Infliximab shortage
As of 31 Oct 2026, Infliximab has a reported shortage in 2 of the 5 countries we track (Austria, Belgium), covering 5 products.
Countries2/5
Products5packs or presentations
Short since10 Aug 20263 months ago
Earliest return31 Oct 2026company estimate
No return date0products
Main reasonIncreased demand
Timeline
AustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 28 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 120 mg Injektionslösung im Fertigpen, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 12 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 14 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 3 Stück limited | Celltrion Healthcare Hungary Ltd. | 14 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| BE | Remsima 120 mg (Orifarm) inj. sol. s.c. pre-filled pen 6 x 1 ml | Celltrion Healthcare Hungary | 10 Aug 2026 | 31 Oct 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.